RxDoctor Payments Data

Paul Jett, MD

Pain Medicine · Kingsport, TNNPI 1780634469

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Ipsen Biopharmaceuticals, Inc accounts for 61.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $3,324 and has fallen 88.8% since, to $371 in 2025.

$5,531in general payments, 2019–2025

Across 116 payments — averaging $47.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ipsen Biopharmaceuticals, Inc$3K
  • Scilex Pharmaceuticals Inc.$276
  • Collegium Pharmaceutical, Inc.$270
  • AbbVie$245
  • Medtronic$241
  • Nevro Corp.$174
  • plus $916 from 18 others

What the payments were for

  • Speaking & faculty fees$1,05619%
  • Travel & lodging$2,00436%
  • Food & beverage$2,47145%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,531 in reported general payments places this provider in the 55th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$77,545
Medicare patients
263
Services billed
824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$1,102
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen44$1,098
Pregabalin43$849
Gabapentin48$702
Morphine Sulfate ErMorphine Sulfate21$585
Baclofen21$359
Duloxetine Hcl17$262
Oxycodone Hcl17$248
Celecoxib13$190
Tizanidine Hcl20$138

Paid to pharmacies, not to this prescriber.

Other pain medicine in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →